BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36200933)

  • 1. Clinical and laboratory findings of primary Sjögren's syndrome patients without sicca symptoms.
    Chatzis LG; Koulouri V; Baldini C; Pezoulas VC; Voulgari PV; Skopouli FN; Fotiadis DI; Tzioufas AG; Goules AV
    Clin Exp Rheumatol; 2022 Dec; 40(12):2298-2302. PubMed ID: 36200933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical phenotype of primary Sjögren's syndrome patients with lymphadenopathy.
    Stergiou IE; Chatzis LG; Pezoulas VC; Baldini C; Fotiadis DI; Voulgarelis M; Tzioufas AG; Goules AV
    Clin Exp Rheumatol; 2022 Dec; 40(12):2357-2362. PubMed ID: 36541237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
    La Rocca G; Ferro F; Bulleri A; Fulvio G; Fonzetti S; Donati V; Romei C; Mosca M; Baldini C
    Clin Exp Rheumatol; 2022 Dec; 40(12):2344-2349. PubMed ID: 36533977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren's Syndrome.
    Tashbayev B; Rusthen S; Young A; Herlofson BB; Hove LH; Singh PB; Rykke M; Aqrawi LA; Chen X; Utheim ØA; Utheim TP; Palm Ø; Jensen JL
    Sci Rep; 2017 Sep; 7(1):10761. PubMed ID: 28883442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Sjögren's-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjögren's syndrome waiting to be unveiled? A case series and review of literature.
    Mittal GK; Mittal S; Kaur H; Stephen SR; Sekhar S; Sureshbabu S; Sandhya P
    Rheumatol Int; 2021 Oct; 41(10):1855-1866. PubMed ID: 33040168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine tear levels in primary Sjögren's syndrome and their relationship with symptoms.
    Hernández-Molina G; Ruiz-Quintero N; Lima G; Hernández-Ramírez D; Llorente-Chávez A; Saavedra-González V; Jiménez-Soto R; Llorente L
    Int Ophthalmol; 2022 Aug; 42(8):2355-2361. PubMed ID: 35059930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
    Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
    Front Immunol; 2021; 12():673658. PubMed ID: 34012457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren's and non-Sjögren's sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature.
    Pucino V; Turner JD; Nayar S; Kollert F; Rauz S; Richards A; Higham J; Poveda-Gallego A; Bowman SJ; Barone F; Fisher BA
    RMD Open; 2022 May; 8(1):. PubMed ID: 35589331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
    Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
    Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
    Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
    Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liposomal local therapy as treatment for sicca symptoms in patients with primary Sjögren's syndrome].
    Hofauer B; Bas M; Manour N; Knopf A
    HNO; 2013 Nov; 61(11):921-7. PubMed ID: 23868654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation Between Subjective and Objective Severity of Oral and Ocular Dryness in Primary Sjögren Syndrome.
    Ripsman DA; Bookman AAM
    J Rheumatol; 2021 Aug; 48(8):1290-1294. PubMed ID: 33934073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with non-Sjögren's sicca report poorer general and oral health-related quality of life than patients with Sjögren's syndrome: a cross-sectional study.
    Tashbayev B; Garen T; Palm Ø; Chen X; Herlofson BB; Young A; Hove LH; Rykke M; Singh PB; Aqrawi LA; Utheim ØA; Utheim TP; Jensen JL
    Sci Rep; 2020 Feb; 10(1):2063. PubMed ID: 32034249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
    Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sicca symptoms are associated with similar fatigue, anxiety, depression, and quality-of-life impairments in patients with and without primary Sjögren's syndrome.
    Milin M; Cornec D; Chastaing M; Griner V; Berrouiguet S; Nowak E; Marhadour T; Saraux A; Devauchelle-Pensec V
    Joint Bone Spine; 2016 Dec; 83(6):681-685. PubMed ID: 26774177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative power of salivary gland ultrasound in relation to symptom-based endotypes in suspected and definite primary Sjögren's Syndrome.
    Deroo L; Achten H; De Boeck K; Genbrugge E; Bauters W; Roels D; Dochy F; Creytens D; De Craemer AS; Van den Bosch F; Elewaut D; Peene I
    Semin Arthritis Rheum; 2022 Oct; 56():152075. PubMed ID: 35907342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical determinants of vaginal dryness in patients with primary Sjögren's syndrome.
    Farenhorst CA; de Wolff L; Arends S; van Nimwegen JF; Kroese FGM; Verstappen GM; Bootsma H
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):73-79. PubMed ID: 34665706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
    Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
    Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.